PharmaCyte Biotech, Inc. (PMCB)

NASDAQ: PMCB · Real-Time Price · USD

1.000

-0.010 (-0.99%)

At close: Oct 10, 2025, 4:00 PM EDT

1.000

0.00 (0.00%)

After-hours: Oct 10, 2025, 5:39 PM EDT

PharmaCyte Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2008 - 2020
Period Ending	Oct '25 Oct 10, 2025	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	2008 - 2020
Market Cap	7	8	17	49	48	44	Upgrade
Market Cap Growth	-49.40%	-50.55%	-65.25%	1.57%	10.69%	5.15%	Upgrade
Enterprise Value	-6.64	-7.11	-21.27	-19	-37.12	41.41	Upgrade
Last Close Price	1.00	1.24	2.12	2.92	2.33	27.43	Upgrade
PE Ratio	160.47	0.39	-1.18	-13.27	-8.63	-11.20	Upgrade
PB Ratio	0.16	0.16	0.62	0.67	0.54	6.53	Upgrade
P/TBV Ratio	0.16	0.18	0.74	0.78	0.40	5.95	Upgrade
P/FCF Ratio	-	-2.83	-7.92	-12.93	-11.73	-13.09	Upgrade
P/OCF Ratio	-	-2.83	-7.92	-12.93	-11.73	-13.09	Upgrade
EV/EBITDA Ratio	-	1.62	2.50	2.94	8.45	-11.43	Upgrade
EV/EBIT Ratio	-	1.62	2.50	2.94	8.45	-11.43	Upgrade
EV/FCF Ratio	-	2.39	9.89	5.01	9.02	-12.43	Upgrade
Quick Ratio	17.01	6.60	6.76	115.99	121.24	3.04	Upgrade
Current Ratio	18.01	7.68	6.80	116.18	121.38	3.14	Upgrade
Return on Equity (ROE)	-2.59%	77.08%	0.67%	-5.31%	-8.78%	-60.35%	Upgrade
Return on Assets (ROA)	-7.90%	-7.61%	-12.79%	-7.88%	-8.96%	-53.39%	Upgrade
Return on Capital (ROIC)	-11.62%	-16.69%	-81.57%	-125.86%	-85.63%	-70.44%	Upgrade
Return on Capital Employed (ROCE)	-8.39%	-8.36%	-13.61%	-7.94%	-9.09%	-61.33%	Upgrade
Earnings Yield	0.65%	257.26%	-84.91%	-7.53%	-11.59%	-8.93%	Upgrade
FCF Yield	-	-35.34%	-12.63%	-7.74%	-8.53%	-7.64%	Upgrade
Buyback Yield / Dilution	25.97%	30.17%	165.48%	27.65%	-180.95%	-10.77%	Upgrade
Total Shareholder Return	-	30.17%	165.48%	27.65%	-180.95%	-10.77%	Upgrade

Updated Sep 15, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q